“…Antibodies, plasmids and other reagents The following monoclonal antibodies were used: 3D3 (anti-D1O TCR, mouse IgGI) (Kaye et al, 1983); C193.5A (anti-D1O TCR, mouse IgGI) (Tite et al, 1986a); F23.1 (anti-Vf38. 1, mouse IgG2a) (Staerz et al, 1985); YCD3-1 (anti-mouse CD3e, rat IgG2c) (Portolds et al, 1989a); GK1.5 (antimouse CD4, rat IgG2b) (Dialynas et al, 1983); YT4.2 (anti-mouse CD4, rat IgG2a) (Janeway Jr et al, 1987); M17/5 (anti-CD lla, rat IgG2a) (Sanchez-Madrid et al, 1982); M1/70 (anti-CDlIb, rat IgG2b) (Springer et al, 1979); M1/9.3 (pan-CD45, rat IgG2a) (Coffman, 1982); and Y-19 (anti-Thy-i, rat IgG) (Jones and Janeway, 1981) were obtained from Dr Charles A.Janeway Jr, Yale University School of Medicine, New Haven, CT. All antibodies were purified from hybridoma supematants by affinity chromatography over protein A -Sepharose columns (Pharmacia).…”